Keurig Dr Pepper Unveils Bold New Flavors Across Iconic U.S. Cold Beverages Portfolio
Dr Pepper Blackberry, available today, is the first variety to release
BURLINGTON, Mass., and FRISCO, Texas, Feb. 5, 2025 /PRNewswire/ -- Keurig Dr Pepper (KDP) today unveiled its exciting 2025 new flavor lineup in the U.S., featuring beloved brands such as Dr Pepper®, 7UP®, A&W® and Snapple ®. These new offerings are being introduced after a successful year of KDP flavor innovation in 2024, notably the viral popularity of Dr Pepper Creamy Coconut - the Company's most successful limited-time-offering carbonated soft drink (CSD) to date - and the introduction of Canada Dry Fruit Splash Cherry, which achieved the top spot among all new CSD flavor innovations for the year1.
"Our 2025 cold beverage pipeline builds on our strong track record of delivering successful consumer-centric innovation across our portfolio of legendary brands," said Eric Gorli, President, U.S. Refreshment Beverages at Keurig Dr Pepper. "Our experts, from flavor scientists to trend spotters, have crafted a dynamic lineup across soft drinks, waters, teas and juices that will offer consumers nationwide even more choice through new fruit flavors, modern twists on familiar favorites and zero sugar options."
New flavors launching nationally within KDP's owned cold beverage portfolio include the following:
Dr Pepper Blackberry, launching today, is the newest permanent variety from the beloved brand, combining the original 23 flavors of Dr Pepper with the rich sweetness of blackberry flavor. Recent data shows high consumer interest for the flavor, with blackberry-flavored CSDs growing more than 2x faster than the CSD category in dollar sales last year2. Dr Pepper Blackberry will be available nationwide in regular and zero sugar varieties across a range of pack sizes, plus fountain and frozen dispensed formats.
7UP Tropical is a cool, crisp combination of 7UP, the #2 lemon-lime carbonated soft drink3, blended with tropical flavors of mango and peach and bursting with summery vibes. Launching as a permanent flavor in February, the regular and zero sugar versions will be available nationwide in 12 oz 12-packs.
Snapple Peach Tea & Lemonade combines the brand's #1 tea flavor4 with a citrusy tang of classic lemonade. This permanent innovation will launch in March and will be available nationwide in a variety of pack sizes.
Bai Simbu Strawberry and Bai Shala Coconut Strawberry, two permanent additions to the Bai lineup that feature the most hydrating berry5 and are sweetened with plant-based stevia, will launch later this month. Both varieties support a healthy immune system, with Simbu Strawberry providing a good source of Vitamin C and Zinc and Shala Coconut Strawberry a good source of Vitamin E and Zinc.
A&W Ice Cream Sundae offers a nostalgic treat, inspired by the combined flavors of sweet vanilla ice cream with the rich indulgence of fudge flavor. Available in both regular and zero sugar options, it comes in 12 oz 12-packs and will be offered for a limited time starting in August.
RC Cola Zero Sugar brings the iconic cola taste with zero sugar for the first time to expanded retailers nationally in February in both 12 oz 12-packs and 2-liter options.
In addition to its nationwide launches, KDP will introduce a variety of retailer exclusive and regional offerings throughout the year from brands including Sunkist, Crush, Mott's and more. Visit KeurigDrPepper.com or follow Keurig Dr Pepper on Instagram (@keurigdrpepper) to stay up to date with all the latest news about our iconic brands and more throughout the year.
About Keurig Dr Pepper Keurig Dr Pepper (Nasdaq: KDP) is a leading beverage company in North America, with a portfolio of more than 125 owned, licensed and partner brands and powerful distribution capabilities to provide a beverage for every need, anytime, anywhere. With annual revenue of approximately $15 billion, we hold leadership positions in beverage categories including soft drinks, coffee, tea, water, juice and mixers, and have the #1 single serve coffee brewing system in the U.S. and Canada. Our innovative partnership model builds emerging growth platforms in categories such as premium coffee, energy, sports hydration and ready-to-drink coffee. Our brands include Keurig®, Dr Pepper®, Canada Dry®, Mott's®, A&W®, Snapple®, Peñafiel®, 7UP®, Green Mountain Coffee Roasters®, Clamato®, Core Hydration® and The Original Donut Shop®. Driven by a purpose to Drink Well. Do Good., our 28,000 employees aim to enhance the experience of every beverage occasion and to make a positive impact for people, communities and the planet. For more information, visit www.keurigdrpepper.com and follow us on LinkedIn.
Investors:
Investor Relations Keurig Dr Pepper T: 888-340-5287 / IR@kdrp.com
Media:
Katie Gilroy Keurig Dr Pepper T: 781-418-3345 / katie.gilroy@kdrp.com
1 Source: Circana Total US - Multi Outlet + Conv Time: Calendar Year 2024 Ending 12-29-24 2 Circana, MULO+C, Calendar Year 2024 $ Sales 3 Circana Market Advantage, Total MULO+C, 52W ending 12.29.24 4 Circana Snapple POS Dollar Sales Data L52W through 12.29.24 5 USDA FoodData Central. Strawberries, raw – up to 91% water content
View original content to download multimedia:https://www.prnewswire.com/news-releases/keurig-dr-pepper-unveils-bold-new-flavors-across-iconic-us-cold-beverages-portfolio-302368819.html
SOURCE Keurig Dr Pepper
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
Lemonade (LMND) Reports Q1 Earnings: What Key Metrics Have to Say
Lemonade (LMND) reported $151.2 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 27%. EPS of -$0.86 for the same period compares to -$0.67 a year ago. The reported revenue represents a surprise of +5.05% over the Zacks Consensus Estimate of $143.93 million. With the consensus EPS estimate being -$0.94, the EPS surprise was +8.51%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Lemonade performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: In force premium (end of period): $1.01 billion compared to the $999.35 million average estimate based on four analysts. Premium per Customer (end of period): $396 versus $394.15 estimated by four analysts on average. Customers (end of period): 2,545,496 versus the four-analyst average estimate of 2,535,658. Net loss ratio: 82% versus the four-analyst average estimate of 89%. Gross loss ratio: 78% compared to the 80.8% average estimate based on four analysts. Net investment income: $9.50 million versus the four-analyst average estimate of $8.45 million. The reported number represents a year-over-year change of +25%. Ceding commission income: $26.90 million versus $22.06 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +28.1% change. Commission income: $10.50 million versus the four-analyst average estimate of $8.02 million. The reported number represents a year-over-year change of +72.1%. Net earned premium: $104.30 million compared to the $105.18 million average estimate based on four analysts. The reported number represents a change of +23.6% year over year. View all Key Company Metrics for Lemonade here>>>Shares of Lemonade have returned +6.7% over the past month versus the Zacks S&P 500 composite's +11.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lemonade, Inc. (LMND) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
16 hours ago
- Yahoo
Lemonade First Quarter 2025 Earnings: Beats Expectations
Revenue: US$151.2m (up 27% from 1Q 2024). Net loss: US$62.4m (loss widened by 32% from 1Q 2024). US$0.86 loss per share (further deteriorated from US$0.67 loss in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) also surpassed analyst estimates by 7.5%. Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Performance of the American Insurance industry. The company's shares are up 4.6% from a week ago. You should always think about risks. Case in point, we've spotted 3 warning signs for Lemonade you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Luckily for you, StockStory helps you navigate which companies are truly worth holding. That said, here is one low-volatility stock that could offer consistent gains and two that may not deliver the returns you need. Rolling One-Year Beta: 0.15 Born out of a 2018 merger between Keurig Green Mountain and Dr Pepper Snapple, Keurig Dr Pepper (NASDAQ:KDP) is a consumer staples powerhouse boasting a portfolio of beverages including sodas, coffees, and juices. Why Does KDP Worry Us? Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 6.5% over the last three years was below our standards for the consumer staples sector Expenses have increased as a percentage of revenue over the last year as its operating margin fell by 5.7 percentage points ROIC of 5.7% reflects management's challenges in identifying attractive investment opportunities Keurig Dr Pepper is trading at $32.63 per share, or 15.8x forward P/E. Check out our free in-depth research report to learn more about why KDP doesn't pass our bar. Rolling One-Year Beta: 0.39 Named after the Massachusetts river where it was founded in 1947, Charles River Laboratories (NYSE:CRL) provides non-clinical drug development services, research models, and manufacturing support to pharmaceutical and biotechnology companies. Why Are We Hesitant About CRL? Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth Forecasted revenue decline of 2.6% for the upcoming 12 months implies demand will fall off a cliff Eroding returns on capital from an already low base indicate that management's recent investments are destroying value Charles River Laboratories's stock price of $140 implies a valuation ratio of 14.8x forward P/E. Read our free research report to see why you should think twice about including CRL in your portfolio, it's free. Rolling One-Year Beta: 0.65 Selling excess inventory or overstocked items from other retailers, Ross Stores (NASDAQ:ROST) is an off-price concept that sells apparel and other goods at prices much lower than department stores. Why Could ROST Be a Winner? Offensive push to build new stores and attack its untapped market opportunities is backed by its same-store sales growth Same-store sales growth averaged 3.5% over the past two years, showing it's bringing new and repeat shoppers into its stores Stellar returns on capital showcase management's ability to surface highly profitable business ventures, and its returns are climbing as it finds even more attractive growth opportunities At $142.24 per share, Ross Stores trades at 21.6x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free.
